QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Announces API Synthesis of Multiple Tryptamine Derivatives
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc.,…